Delivery Order SPE2DB20D1051-SPE2DB25FD5ZN
Award Date
10/28/24
Potential Completion Date
10/29/24
Potential Value
$2.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,757.38 firm fixed-price delivery order is for the supply of OPZELURA 1.5% Cream in 60-gram sizes. The contract has an ultimate completion date of March 26, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,468.03 firm-fixed-price delivery order is for the supply of OPZELURA 1.5% cream, a pharmaceutical product. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA), a defense agency. The $2,548.53 Firm Fixed Price contract is for the delivery of the pharmaceutical product OPZELURA 1.5% Cream in 60 gram units, with a performance period ending on June 13, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,902.09 firm fixed-price delivery order is for the supply of OPZELURA 1.5% Cream, a pharmaceutical product, to support federal healthcare programs. The contract has a completion date of February 7, 2024 and was awarded on February 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,451.14 firm fixed-price delivery order is for the pharmaceutical product OPZELURA 1.5% CREAM 60GM. The contract has an ultimate completion date of March 26, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,276.75, is for the delivery of OPZELURA 1.5% Cream (60 GM). This appears to be a Firm Fixed Price Delivery Order contract, with an ultimate completion date of November 1, 2024. The contract is not designated with a set-aside requirement, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $47,429.17 Firm Fixed Price Delivery Order is for the supply of OPZELURA 1.5% Cream, a pharmaceutical product. The contract has an ultimate completion date of July 12, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of OPZELURA 1.5% cream, a pharmaceutical product. The $5,078.49 firm fixed-price delivery order has an ultimate completion date of December 3, 2024. No set-aside designation was used for this award. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order (SPE2DB20D3505|SPE2DB24FT9L0) valued at $4,648.94 for the supply of a prescription medication, OPZELURA 1.5% Cream. The award was made by the Defense Logistics Agency (DLA), a defense agency, on March 19, 2024, with a completion date of March 20, 2024. The contract is a Firm Fixed Price agreement with no set-aside designation, indicating open competition. Amerisourcebergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,665.85 firm fixed-price delivery order is for the supply of OPZELURA 1.5% cream (60 gm) to support federal healthcare programs. The contract has an ultimate completion date of February 4, 2025. Amerisourcebergen holds a large $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...